Regeneron Stock Sinks on Disappointing Product sales of Eylea Vaccine
Regeneron Pharmaceuticals inventory was tumbling just after the medication maker described reduced product sales of its ...
Read moreRegeneron Pharmaceuticals inventory was tumbling just after the medication maker described reduced product sales of its ...
Read moreAstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 ...
Read moreWe've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a ...
Read moreAstraZeneca agreed to invest in U.S. biotech enterprise CinCor Pharma in a offer perhaps valued at ...
Read moreMy 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to ...
Read moreMy 2023 biotech outlook calls for ongoing momentum in title variations. I just will need to ...
Read moreAbbVie Inc. executives decreased their outlook for the quarter and yr in a filing with the ...
Read moreFinancial institution of The us analysts upgraded BioNTech SE stock to acquire from maintain on Thursday, ...
Read moreClovis Oncology Inc., maker of the ovarian and prostate most cancers drug Rubraca, filed for individual ...
Read moreAmgen attained a deal to invest in drug corporation Horizon Therapeutics for $116.50 a share in ...
Read more